The EMTRAIN PhD Workshops

Introduction:

In total 135 students from 17 companies, 56 universities and 22 different countries have attended the five EMTRAIN Public-Private Partner (PPP) PhD workshops and most are members of the social network. The feedback from the participants has proven that the workshops were extremely successful in producing a cohort of industry-aware PhD students. The background has been published: It pays to promote joint PhD programmes between academia and the private sector. Journal of Medicines Development Sciences, vol.1 (2): 37–40. https://www.researchgate.net/publication/294109604_It_pays_to_promote_joint_PhD_programmes_between_academia_and_the_private_sector

The workshop objectives were:

1.To create a forum for PPP PhD-students where they meet, share experience and connect as a step towards growing into their role as industry-aware scientists.
2.To create a network of PPP PhD students.
3.To enhance the connection between industry and academia.
4.To increase drug industry awareness in PhD students.

The following is a repository of the workshop programmes and we hope that others will “steal with pride” when they are designing workshops.

 

2016 PhD Workshop: Innovative approaches to address unmet needs in common and rare diseases

Host/ Location:  24-27 April 2016, Bayer, Berlin, Germany

Agenda

Call for application

Summary

Photo

 

2015 PhD Workshop: Translational medicine

Host/Location:  26-29 April 2015, Janssen Pharmaceutica, Beerse, Belgium

Agenda

Evaluation

Call for application

Photo

 

2014 PhD Workshop: The role of discovery in the field of drug development

Host/Location: 11-14 May, UCB, Brussels, Belgium

Agenda

Evaluation

Call for application

Photo

 

2013 PhD Workshop: Interaction with academia, SME, and activities in emerging countries

Host/Location: 14-17 April 2013, Glaxo SmithKline, Stevenage, UK

Agenda

Evaluation

Photo

 

2012 PhD Workshop: Importance of multidisciplinary research for drug discovery and development

Host/Location:  23-26 February 2012, AstraZeneca, Alderley Park, Manchester, UK

Agenda

Evaluation

Call for application

Photo

 

 

Milestone No.

Milestone name

WPs involved

Expected delivery date 1.10.2009

Means of verification
1 Development of mapping
and gap analysis
methodology		 WP3 M12 report
2 Initial survey on existing
training programme and
tools		 WP 5-6-7-8 M12 report
3 Communication platform
for T14, among the other
IMI topics		 WP9 M12 homepage
4 Action plan for common
training methodologies
and tools		 WP8 M18 report
5 Action plan for common
training methodologies
and tools		 WP4 M24 report
6 Criteria for harmonisation
of developed E&T
programmes in IMI		 WP4 M36 report
7 Strategic report WP2 M12 (yearly strategic reports) report
8 Online catalogue
providing a syllabus for
pan-European
educational programmes
in drug development		 WP9 (in
collaboration
with WP5-7)		 M36 homepage
9 National implementation
and extension of
programmes where
feasible		 WP2/WP4 M84 report
 

 



  1. The Steering Committee presides over the Strategic Coordination Board, decides on and implements recommendations made by the Strategic Coordination Board. The Strategic Coordination Board will provide mutual interactions with the other educational topics of the IMI JU.
  2. The Managing Coordination Board will liaise via the Project Office with the Steering Committee. 
  3. Operational management of the Steering Committee shall be provided via the Project Office, which is located at the Medizinische Universitaet Wien. 
  4. The Project Office will coordinate the activities of work packages through direct interaction with WP Leaders, oversee progress and track timely release of deliverables in work packages. 
  5. The External Advisory Board will serve as advisor to the Steering Committee. Representatives will be invited by the Coordinator. Meetings shall be held at least annually. 
  6. The Network Committee will serve as advisor to the Steering Committee. Representatives will be invited by the Coordinator. Meetings shall be held at least annually. 
  7. The Project Office will serve as interface for national liaison offices.  
  8. The Managing Coordination Board will oversee progress and provide interaction between work packages. 
  9. Interface on Work Package level (WP2-5 and 7-9) between WP Leaders of all E&T IMI Topics.

New on-course® article published

Great success for EMTRAIN: The article "on-course® portal: a tool for in-service training and career development for biomedical scientists" was published in Drug Discovery Today.

New EMTRAIN article has been published

Article about Continuing Professional Development published

The article "Teaching in a Continual Professionally Developing World", written by Shirley Price and Wolf See, who represents Bayer in the EMTRAIN consortium, is published in the recent edition of the nexus Newsletter 3/2012 of the German Rectors' Conference.

Course quality criteria published

EMTRAIN has developed a position paper with their IMI E&T partner projects.

Most recent publication on PhD programmes

  1. IMI E&T Projects participated in BioVision 2013
  2. EMTRAIN Mission
  3. Mission
  4. Governance Structure

Subcategories

Partners

About